We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.55%
2 Healthcare 10.82%
3 Consumer Discretionary 9.19%
4 Financials 8.34%
5 Communication Services 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RERE
4301
ATRenew
RERE
$1B
$12K ﹤0.01%
4,044
-12,750
-76% -$37.5K
REVG
4302
DELISTED
REV Group
REVG
$12K ﹤0.01%
1,104
-18,106
-94% -$214K
RICK icon
4303
RCI Hospitality Holdings
RICK
$223M
$12K ﹤0.01%
248
+90
+57% +$5.17K
RKDA icon
4304
Arcadia Biosciences
RKDA
$1.24M
$12K ﹤0.01%
302
+296
+4,933% +$13.6K
SABS icon
4305
SAB Biotherapeutics
SABS
$341M
$12K ﹤0.01%
818
+645
+373% +$13.5K
SEB icon
4306
Seaboard Corp
SEB
$4.04B
$12K ﹤0.01%
3
-1
-25% -$4.03K
SELF
4307
Global Self Storage
SELF
$59.7M
$12K ﹤0.01%
2,199
+1,179
+116% +$7K
SGLY icon
4308
Singularity Future Technology
SGLY
$4.75M
$12K ﹤0.01%
28
+26
+1,300% +$21.3K
SMR icon
4309
NuScale Power
SMR
$4.01B
$12K ﹤0.01%
+1,227
New +$12.3K
STIM icon
4310
Neuronetics
STIM
$209M
$12K ﹤0.01%
3,879
-20,955
-84% -$60.8K
STR
4311
DELISTED
Sitio Royalties
STR
$12K ﹤0.01%
510
+395
+343% +$10.9K
TLYS icon
4312
Tilly's
TLYS
$122M
$12K ﹤0.01%
1,643
+1,227
+295% +$10.2K
TNXP icon
4313
Tonix Pharmaceuticals
TNXP
$211M
– –
0
– –
TSHA icon
4314
Taysha Gene Therapies
TSHA
$1.85B
$12K ﹤0.01%
3,259
+1,659
+104% +$6.58K
TWIN icon
4315
Twin Disc
TWIN
$346M
$12K ﹤0.01%
1,269
+1,265
+31,625% +$15.5K
AD
4316
Array Digital Infrastructure
AD
$3.09B
$12K ﹤0.01%
411
-1,881
-82% -$56.4K
VNQI icon
4317
Vanguard Global ex-US Real Estate ETF
VNQI
$3.52B
$12K ﹤0.01%
277
+200
+260% +$9.55K
VRCA icon
4318
Verrica Pharmaceuticals
VRCA
$83.8M
$12K ﹤0.01%
654
-1,322
-67% -$66.4K
VRME icon
4319
VerifyMe
VRME
$9.05M
$12K ﹤0.01%
5,930
+4,189
+241% +$11.3K
VSTM icon
4320
Verastem
VSTM
$594M
$12K ﹤0.01%
856
-1,882
-69% -$30K
WINT
4321
DELISTED
Windtree Therapeutics
WINT
$12K ﹤0.01%
+1
New +$29.5K
XBIO icon
4322
Xenetic Biosciences
XBIO
$7.24M
$12K ﹤0.01%
1,438
+1,258
+699% +$10.2K
TEN
4323
Tsakos Energy Navigation Ltd
TEN
$1.25B
$12K ﹤0.01%
+1,389
New +$15.1K
SEI
4324
Solaris Energy Infrastructure
SEI
$3.98B
$12K ﹤0.01%
1,114
-9,513
-90% -$115K
WINV
4325
DELISTED
WinVest Acquisition Corp. Common Stock
WINV
$12K ﹤0.01%
1,196
-90
-7% -$894
171 172
173
174 175

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.